ORGS — Orgenesis Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.56m
- $17.16m
- $1.04m
Brief: Orgenesis Inc, Neil Reithinger Informed Co Of His Decision To Resign As Chief Financial Officer, Treasurer And Secretary Of Co
Brief: Orgenesis Announces Name Change Of Morgenesis Business Unit To Octomera
Brief: Orgenesis Provides Business Update For The First Quarter Of 2023
Brief: Orgenesis Says On March 27, Unit Entered Into Convertible Loan Agreement With Yehuda Nir
Orgenesis Inc reports results for the quarter ended in December - Earnings Summary
Brief: Orgenesis Reports 98% Year-Over-Year Increase In Revenue To $13.6 Million For The Fourth Quarter Of 2022
Brief: Orgenesis And Kurve Therapeutics Announce Pre-Clinical Study Results For A Cell-Based Oncolytic Virus Bearing Product
Orgenesis Inc reports results for the quarter ended in September - Earnings Summary
Brief: Orgenesis Announces Third Quarter Results
U.S. STOCKS ON THE MOVE-Boeing, U.S. energy, Delek US
U.S. STOCKS ON THE MOVE-Kosmos Energy, Scisparc, Walgreens
Orgenesis up after PE firm injects $50 mln into unit
Brief: Orgenesis Secures Up To $50 Million Subsidiary-Level Investment From Metalmark Capital
Orgenesis Inc expected to post a loss of 2 cents a share - Earnings Preview
Orgenesis Inc reports results for the quarter ended in June - Earnings Summary
Brief: Orgenesis Achieves Revenue Of $7.2 Million For First Quarter Of 2022
Orgenesis Inc reports results for the quarter ended in March - Earnings Summary
Orgenesis Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Orgenesis Led Consortium Awarded €4M European Innovation Council Pathfinder Grant